Brand / product

Empaphage-M

Empagliflozin + Metformin · 5 mg + 500 mg

ShareSend this page
₨ Official source-observed price PKR 385.37 7's
PKR 55.05 / tablet
✓ Official DRAP price source observed · Source checked 2026-11-13
Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 55.05/ tablet
Price position13% above medianvs like-for-like peer median
Peer comparators20current-price listings
🔒
MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence
View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic
Empagliflozin + Metformin
Therapeutic area
Endocrine & metabolic
Drug class
Antidiabetic medicines
ATC
A10BA
Strength
5 mg + 500 mg
Dosage form
Tablet
Pack
7's
Registration no.
114574
Price record verified
2026-08-09
Latest DRAP source check
2026-11-13 03:02

Manufacturer

Martin Dow Marker Limited

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

What Empaphage-M (Empagliflozin with metformin) is used for

This is a prescription tablet for type 2 diabetes that contains two diabetes medicines in one. Empagliflozin is an SGLT2 inhibitor: it helps the kidneys get rid of extra sugar in the urine. Metformin mainly cuts down the amount of sugar the liver makes. Together they lower blood sugar. It is used alongside a healthy diet and exercise, and it can replace taking empagliflozin and metformin as two separate tablets.

  • Type 2 diabetes in adults, when metformin on its own does not control blood sugar well enough
  • Type 2 diabetes alongside other diabetes medicines, including insulin, when they are not controlling blood sugar well enough
  • People who already take empagliflozin and metformin as separate tablets and want to switch to one combined tablet
  • The Irish product leaflet also allows use in children aged 10 and over with type 2 diabetes; a doctor decides if it is suitable

Get medical help straight away if

  • Get emergency help for signs of lactic acidosis (a rare, dangerous build-up of acid): being sick, stomach pain, muscle cramps, feeling very weak or tired, trouble breathing or fast deep breathing, feeling very cold, or a slow or fast heartbeat. Stop the tablets and get help straight away.
  • Get urgent help for signs of diabetic ketoacidosis (DKA): feeling or being sick, very strong thirst, stomach pain, fast or deep breathing, confusion, unusual sleepiness, quick weight loss, or breath that smells sweet or fruity. This can happen even when blood sugar is normal. Stop the tablets and contact a doctor urgently.
  • Get urgent help for severe pain, tenderness, redness or swelling of the genitals or the area between the genitals and the bottom, with a fever or feeling unwell. This can be a rare, serious infection (Fournier's gangrene).
  • Call an ambulance for a severe allergic reaction: swelling of the face, lips, tongue or throat, or difficulty breathing or swallowing.

Side effects, warnings and interactions for Empagliflozin with metformin

Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.

Our condition guides that mention Empagliflozin + Metformin

From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Empagliflozin + Metformin is right for you and the dose.

Summary

About Empaphage-M 5 mg + 500 mg tablet

Empaphage-M 5 mg + 500 mg tablet contains Empagliflozin + Metformin 5 mg + 500 mg. It is registered with DRAP by Martin Dow Marker Limited (registration no. 114574). Its official price is PKR 385.37 for a pack of 7's, about PKR 55.05 per tablet. This price has applied since 23 July 2026. It is sold in 5 pack sizes: 7's, 10's, 14's, 28's and 30's. Empaphage-M is also available as 10 mg + 1000 mg tablet, 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet and 12.5 mg + 850 mg tablet. 7 other brands of Empagliflozin + Metformin 5 mg + 500 mg (tablet) are registered in Pakistan. Compare all brands and prices →

Pack sizes

Empaphage-M 5 mg + 500 mg pack sizes and prices

PackOfficial pricePer tablet
7's (this page)PKR 385.37PKR 55.05
10'sPKR 549.15PKR 54.92
14'sPKR 769.14PKR 54.94
28'sPKR 1,506.17PKR 53.79
30'sPKR 1,615.35PKR 53.85
Same brand

Other strengths of Empaphage-M

Alternatives (substitutes): same medicine, strength and form

All 7 other brands of Empagliflozin + Metformin 5 mg + 500 mg tablet in Pakistan

These 7 brands are alternatives (substitutes) to Empaphage-M: each contains Empagliflozin + Metformin 5 mg + 500 mg tablet. Ask your doctor or pharmacist before you switch brands.

Sorted by price per tablet, lowest first. The lowest is Sciampa-M (Scilife Pharma Private Limited) at PKR 41.73 per tablet; the highest is Empozin M at PKR 62.15. All prices are official DRAP prices.

BrandCompanyPackOfficial pricePer unit
Sciampa-MScilife Pharma Private Limited14'sPKR 584.28PKR 41.73 / tablet
Glempa-MNabiqasim Industries (Pvt) Ltd10sPKR 483.13PKR 48.31 / tablet
Empator-MMartin Dow Limited14'sPKR 676.66PKR 48.33 / tablet
Diampa-MGetz Pharma (Pvt) Limited14'sPKR 680.82PKR 48.63 / tablet
Adrance-MAtco Laboratories Limited7'sPKR 341.13PKR 48.73 / tablet
Emdagan PlusShaigan Pharmaceuticals (Pvt) Ltd14'sPKR 732.25PKR 52.30 / tablet
Empozin MMacter International Limited14'sPKR 870.08PKR 62.15 / tablet

See every strength and form of Empagliflozin + Metformin →

Where to buy

MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Empaphage-M, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.

Registration holder
Martin Dow Marker Limited, Karachi
DRAP registration
114574
Phone
+92 21 111 111 634
Email
info@martindow.com
Website
https://www.martindowmarker.com/
Contact page
Company contact page

Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.

Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (7's). Current price PKR 385.37, effective 23 Jul 2026.

Cite this price history

MedInfoBase. Empaphage-M 5 mg + 500 mg, 7's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/empaphage-m-5-mg-500-mg-114574-10s-martin-dow-marker-limited/ (accessed 13 November 2026).

Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 385.372026-07-232026-08-09DRAP PharmaPrice IndexCurrent
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 114574
MedInfoBase. (2026). Empaphage-M 5 mg + 500 mg Tablet (7's), Martin Dow Marker Limited — registration and price record [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/brand/empaphage-m-5-mg-500-mg-114574-10s-martin-dow-marker-limited/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 114574.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9